Research map: Predictive Ability of the CHA2DS2‐VA Score for No‐Reflow Phenomenon in ST‐Elevation Myocardial Infarction Patients Undergoing Primary PCI

Back to the article

Papers in this map

  1. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach · Gregory Y.H. Lip · 2009 · 6814 citations · Cited by this paper
  2. From Molecules to Machines: An Integrative Framework Linking Molecular Pathogenesis, Multi‐Factorial Risk, Risk Stratification, Clinical Management, and Artificial Intelligence in QT Prolongation and Sudden Cardiac Death · 2026 · Related
  3. The Thrombolysis in Myocardial Infarction (TIMI) Trial · The TIMI Study Group* · 1985 · 3191 citations · Cited by this paper
  4. Comment on “Apical Sparing of Longitudinal Strain and Myocardial Fibrosis in Hypertensive Patients and Spontaneously Hypertensive Rats: Based on Speckle Tracking and Histological Analysis” · 2026 · Related
  5. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) · Isabelle C. Van Gelder · 2024 · 2934 citations · Cited by this paper
  6. Does Serum γKlotho Truly Provide Incremental Prognostic Value Beyond Established Risk Predictors in Multivessel Coronary Artery Disease? · 2026 · Related
  7. TIMI Frame Count · C. Michael Gibson · 1996 · 1875 citations · Cited by this paper
  8. The Association Between Bending Photoplethysmography Waveform Area Index and Congestive Heart Failure · 2026 · Related
  9. Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial Infarction · Arnoud W.J. van ’t Hof · 1998 · 1307 citations · Cited by this paper
  10. Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023) · 2026 · Related
  11. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort · Konsta Teppo · 2024 · 104 citations · Cited by this paper
  12. Association of 3‐Day Postoperative Blood Glucose Variability With All‐Cause Mortality in ICU Patients After Surgical Repair of Acute Type A Aortic Dissection: A Retrospective Cohort Study Using the MIMIC‐IV Database · 2026 · Related
  13. “No-Reflow” Phenomenon: A Contemporary Review · Gianmarco Annibali · 2022 · 99 citations · Cited by this paper
  14. Clinical and Angiographic Predictors of No‐Reflow and Its Impact on Outcomes in ST‐Elevation Myocardial Infarction: A Retrospective Study · 2026 · Related
  15. Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction · Pernille Gro Thrane · 2023 · 92 citations · Cited by this paper
  16. Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States · 2026 · Related
  17. Plaque Rupture, Compared With Plaque Erosion, Is Associated With a Higher Level of Pancoronary Inflammation · Akihiro Nakajima · 2021 · 84 citations · Cited by this paper
  18. Reconsidering the Clinical Utility of a Body Shape Index for Abdominal Aortic Calcification in Hypertension: From Association to Clinical Applicability · 2026 · Related
  19. Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries · Harmony R. Reynolds · 2022 · 80 citations · Cited by this paper
  20. CHA 2 DS 2 -VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention · Göktürk İpek · 2015 · 77 citations · Cited by this paper
  21. Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature · Sharif A. Sabe · 2022 · 68 citations · Cited by this paper
  22. Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy · Gjin Ndrepepa · 2023 · 55 citations · Cited by this paper
  23. Coronary Inflammation and Plaque Vulnerability: A Coronary Computed Tomography and Optical Coherence Tomography Study · Haruhito Yuki · 2023 · 52 citations · Cited by this paper
  24. Relationship Between Calcified Plaque Burden, Vascular Inflammation, and Plaque Vulnerability in Patients With Coronary Atherosclerosis · Daichi Fujimoto · 2024 · 49 citations · Cited by this paper
  25. CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention · Fardin Mirbolouk · 2018 · 47 citations · Cited by this paper
  26. Sex Difference in Outcomes of Acute Myocardial Infarction in Young Patients · Mitsuaki Sawano · 2023 · 46 citations · Cited by this paper
  27. No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients · Larisa Renata Pantea-Roșan · 2020 · 45 citations · Cited by this paper
  28. No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI) · Jennifer Ann Rossington · 2020 · 28 citations · Cited by this paper
  29. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score · Luke P. Dawson · 2024 · 27 citations · Cited by this paper
  30. Stroke risks in women vs men in Asian patients with atrial fibrillation: A temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores · Wen‐Han Cheng · 2025 · 26 citations · Cited by this paper
  31. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation · Mehmet Kadri Akboğa · 2021 · 25 citations · Cited by this paper
  32. Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability · Daisuke Kinoshita · 2024 · 24 citations · Cited by this paper
  33. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction · Puneet Kumar Aggarwal · 2021 · 23 citations · Cited by this paper
  34. Molecular Mechanisms of Microvascular Obstruction and Dysfunction in Percutaneous Coronary Interventions: From Pathophysiology to Therapeutics—A Comprehensive Review · André Moreira Nicolau · 2025 · 22 citations · Cited by this paper
  35. The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention · Huiliang Liu · 2024 · 20 citations · Cited by this paper
  36. QUANTIFICATION OF THROMBUS BURDEN AS AN INDEPENDENT PREDICTOR OF INTRA-PROCEDURAL NO-REFLOW IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY REVASCULARIZATION · Rajesh Kumar · 2022 · 18 citations · Cited by this paper
  37. Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction · Dongbao Li · 2009 · 16 citations · Cited by this paper
  38. Prognostic implications of ST‐segment elevation in lead aVR in patients with acute coronary syndrome: A meta‐analysis · Aqian Wang · 2020 · 15 citations · Cited by this paper
  39. Gender-related differences in men and women with ST-segment elevation myocardial infarction and incomplete infarct-related artery flow restoration: a multicenter national registry · Małgorzata Zachura · 2018 · 13 citations · Cited by this paper

Source: OpenAlex (CC0)